MGAT3 and Alzheimer disease: The results confirmed the next generation sequencing (NGS) data that showed an increase of NF-κB and BACE1 in cells from AD patients compared to cells from healthy volunteers and a decrease of MGAT3 and VDR in cells from AD patients compared to cells from healthy controls (Table 2).